Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Nickolas Zaller to Hepatitis C

This is a "connection" page, showing publications Nickolas Zaller has written about Hepatitis C.

 
Connection Strength
  
 
 
3.160
  
  1. Pro G, Tompkins DA, Azari S, Zaller N. National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status. Drug Alcohol Depend. 2021 11 01; 228:109092.
    View in: PubMed
    Score: 0.752
  2. Zaller N, Ostrach B. HCV, injection drug use, and the importance of harm reduction in Kenya. Lancet Infect Dis. 2019 11; 19(11):1158-1159.
    View in: PubMed
    Score: 0.654
  3. Zaller ND, Patry EJ, Bazerman LB, Noska A, Kuo I, Kurth A, Beckwith CG. A Pilot Study of Rapid Hepatitis C Testing in Probation and Parole Populations in Rhode Island. J Health Care Poor Underserved. 2016; 27(2A):214-23.
    View in: PubMed
    Score: 0.505
  4. Larney S, Mahowald MK, Scharff N, Flanigan TP, Beckwith CG, Zaller ND. Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health. 2014 Jun; 104(6):e69-74.
    View in: PubMed
    Score: 0.449
  5. Zaller N, Nelson KE, Aladashvili M, Badridze N, del Rio C, Tsertsvadze T. Risk factors for hepatitis C virus infection among blood donors in Georgia. Eur J Epidemiol. 2004; 19(6):547-53.
    View in: PubMed
    Score: 0.220
  6. Larney S, Zaller ND, Dumont DM, Willcock A, Degenhardt L. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations. Ann Epidemiol. 2016 08; 26(8):570-578.e2.
    View in: PubMed
    Score: 0.131
  7. Mahowald MK, Larney S, Zaller ND, Scharff N, Taylor LE, Beckwith CG, Noska A, Rich JD, Flanigan TP. Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012. J Correct Health Care. 2016 Jan; 22(1):41-5.
    View in: PubMed
    Score: 0.126
  8. Larney S, Zaller ND, Degenhardt L. Reply: To PMID 23504650. Hepatology. 2014 Feb; 59(2):733-4.
    View in: PubMed
    Score: 0.110
  9. Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, Rich JD, van den Bergh BJ, Degenhardt L. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013 Oct; 58(4):1215-24.
    View in: PubMed
    Score: 0.107
  10. Taylor LE, Bowman SE, Chapman S, Zaller N, Stein MD, Cioe PA, Maynard MA, McGovern BH. Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Drug Alcohol Depend. 2011 Jul 01; 116(1-3):233-7.
    View in: PubMed
    Score: 0.089
  11. Rich JD, Hogan JW, Wolf F, DeLong A, Zaller ND, Mehrotra M, Reinert S. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend. 2007 Jul 10; 89(2-3):292-7.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.